Puma Biotechnology (NASDAQ:PBYI) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Puma Biotechnology (NASDAQ:PBYI – Free Report) in a report issued on Thursday. The brokerage issued a buy rating on the biopharmaceutical company’s stock. Several other equities research analysts also recently issued reports on PBYI. HC Wainwright reiterated a buy rating and set a $8.00 price objective on shares of […]

Related Keywords

United States ,Troy Edward Wilson ,Maximof Nougues ,Commonwealth Equity Services ,Securities Exchange Commission ,Mackenzie Financial Corp ,Balyasny Asset Management ,Puma Biotechnology Company Profile ,Puma Biotechnology Inc ,Puma Biotechnology ,Free Report ,Exchange Commission ,Director Troy Edward Wilson ,Equity Services ,Street Group ,Financial Corp ,Get Free Report ,Puma Biotechnology Daily ,Nasdaq Pbyi ,Pbyi ,Medical ,Initiated Coverage ,Stocknews Com ,